As shown in Supplementary Fig. 7, the Bcl10−/− mutation also caused partial protection from the clinical signs (P=0.065; two-way ANOVA) and ankle-thickening response (P=0.015; two-way ANOVA) during K/B × N serum-transfer arthritis. The gene discussed is BCL10; the disease is arthritic joint disease.